Latest biopharmaceutical Stories
LYNBROOK, N.Y., May 12, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
The NextGEN(TM) CRISPR genome engineering tools and services provided by Transposagen are ideal when research and drug discovery applications require clean, high-precision genome editing.
CAMEO Phase 2 Clinical Trial of LUM001 Now Enrolling Adults with Primary Sclerosing Cholangitis SAN DIEGO, May 9, 2014 /PRNewswire/ --
BOSTON, May 9, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that its Chairman and CEO, Josef von Rickenbach,
LA JOLLA, Calif., May 7, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc.
MONROVIA, Calif., May 7, 2014 /PRNewswire/ -- Xencor, Inc.
JUPITER, Fla., May 6, 2014 /PRNewswire/ -- Dyadic International, Inc.
LONDON, May 6, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
SEATTLE, May 6, 2014 /PRNewswire/ -- CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc.
SANTA ROSA, Calif., May 5, 2014 /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN), a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics
- The word or words serving to define another word or expression, as in a dictionary entry.